| Jessica Lynn Anglin, NP | |
|
200 Clinic Dr Fl 6, Madisonville, KY 42431-1661 | |
| (812) 477-7246 | |
| (812) 477-7240 |
| Full Name | Jessica Lynn Anglin |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 5 Years |
| Location | 200 Clinic Dr Fl 6, Madisonville, Kentucky |
| Accepts Medicare Assignments | May be. She may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104438902 | NPI | - | NPPES |
| 710053770 | Medicaid | KY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208VP0014X | Pain Medicine - Interventional Pain Medicine | 3014910 (Kentucky) | Secondary |
| 363LF0000X | Nurse Practitioner - Family | 3014910 (Kentucky) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Indiana Exceptional Medical Care | 8527241488 | 15 |
News Archive
Merck Serono, a division of Merck KGaA, Darmstadt, Germany, today announced that Erbitux® (cetuximab) demonstrated a significant improvement in overall survival (OS) when added to standard 1st-line chemotherapy for metastatic colorectal cancer (mCRC) patients with KRAS wild-type tumors.
Where Latinos are born and their immigration status affect the quality of health care they receive in the US, according to Professor Michael Rodr-guez and colleagues from the UCLA Department of Family Medicine and the Network for Multicultural Research on Health and Healthcare based in Los Angeles, California.
Biomagnetics Diagnostics Corp., a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis and malaria detection, and other innovative technologies, today announced the signing of a Letter of Intent (LOI) with Hubei Tianyuan Chemical Co., Ltd. of Yangxin Nacheng Chemical Industry Zone, located in Hubei Province, China.
Mayo Clinic has announced the first U.S. stem cell clinical trial for pediatric congenital heart disease. The trial aims to determine how stem cells from autologous umbilical cord blood can help children with hypoplastic left heart syndrome, a rare defect in which the left side of the heart is critically underdeveloped.
› Verified 8 days ago
| Entity Name | Indiana Exceptional Medical Care |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669708756 PECOS PAC ID: 8527241488 Enrollment ID: O20110330000661 |
News Archive
Merck Serono, a division of Merck KGaA, Darmstadt, Germany, today announced that Erbitux® (cetuximab) demonstrated a significant improvement in overall survival (OS) when added to standard 1st-line chemotherapy for metastatic colorectal cancer (mCRC) patients with KRAS wild-type tumors.
Where Latinos are born and their immigration status affect the quality of health care they receive in the US, according to Professor Michael Rodr-guez and colleagues from the UCLA Department of Family Medicine and the Network for Multicultural Research on Health and Healthcare based in Los Angeles, California.
Biomagnetics Diagnostics Corp., a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis and malaria detection, and other innovative technologies, today announced the signing of a Letter of Intent (LOI) with Hubei Tianyuan Chemical Co., Ltd. of Yangxin Nacheng Chemical Industry Zone, located in Hubei Province, China.
Mayo Clinic has announced the first U.S. stem cell clinical trial for pediatric congenital heart disease. The trial aims to determine how stem cells from autologous umbilical cord blood can help children with hypoplastic left heart syndrome, a rare defect in which the left side of the heart is critically underdeveloped.
› Verified 8 days ago
| Entity Name | Pain Management Centers Of America Psc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992271811 PECOS PAC ID: 2769727114 Enrollment ID: O20181213000858 |
News Archive
Merck Serono, a division of Merck KGaA, Darmstadt, Germany, today announced that Erbitux® (cetuximab) demonstrated a significant improvement in overall survival (OS) when added to standard 1st-line chemotherapy for metastatic colorectal cancer (mCRC) patients with KRAS wild-type tumors.
Where Latinos are born and their immigration status affect the quality of health care they receive in the US, according to Professor Michael Rodr-guez and colleagues from the UCLA Department of Family Medicine and the Network for Multicultural Research on Health and Healthcare based in Los Angeles, California.
Biomagnetics Diagnostics Corp., a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis and malaria detection, and other innovative technologies, today announced the signing of a Letter of Intent (LOI) with Hubei Tianyuan Chemical Co., Ltd. of Yangxin Nacheng Chemical Industry Zone, located in Hubei Province, China.
Mayo Clinic has announced the first U.S. stem cell clinical trial for pediatric congenital heart disease. The trial aims to determine how stem cells from autologous umbilical cord blood can help children with hypoplastic left heart syndrome, a rare defect in which the left side of the heart is critically underdeveloped.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jessica Lynn Anglin, NP 1101 Professional Blvd Ste 100, Evansville, IN 47714-8018 Ph: (812) 477-7246 | Jessica Lynn Anglin, NP 200 Clinic Dr Fl 6, Madisonville, KY 42431-1661 Ph: (812) 477-7246 |
News Archive
Merck Serono, a division of Merck KGaA, Darmstadt, Germany, today announced that Erbitux® (cetuximab) demonstrated a significant improvement in overall survival (OS) when added to standard 1st-line chemotherapy for metastatic colorectal cancer (mCRC) patients with KRAS wild-type tumors.
Where Latinos are born and their immigration status affect the quality of health care they receive in the US, according to Professor Michael Rodr-guez and colleagues from the UCLA Department of Family Medicine and the Network for Multicultural Research on Health and Healthcare based in Los Angeles, California.
Biomagnetics Diagnostics Corp., a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis and malaria detection, and other innovative technologies, today announced the signing of a Letter of Intent (LOI) with Hubei Tianyuan Chemical Co., Ltd. of Yangxin Nacheng Chemical Industry Zone, located in Hubei Province, China.
Mayo Clinic has announced the first U.S. stem cell clinical trial for pediatric congenital heart disease. The trial aims to determine how stem cells from autologous umbilical cord blood can help children with hypoplastic left heart syndrome, a rare defect in which the left side of the heart is critically underdeveloped.
› Verified 8 days ago